Navigation Links
Analysis Of Human Genome To Predict The Development Of Illnesses

The GARBAN project, drawn up by Navarre University, will enable the identification of therapeutic targets for cancer, depression and hepatitis.

The School of Engineering at Navarre University and its Centre for Technical Studies and Research in Gipuzkoa (CEIT) have launched an advanced biochemical analysis tool that will help in predicting the evolution of diseases, accelerate their diagnosis and identify new therapeutic targets (lines of action) for ailments such as cancer, depression and hepatitis.

This bioinformatics tool, designed in collaboration with the Centre for Applied Research in Medicine (CIMA) at Navarre University and known as GARBAN (Genomic Analysis for Rapid Biological Annotation), carries out the following process: firstly, it hierarchically classifies all known genes and proteins according to their molecular function, molecular composition and biological process. With the unknown ones, they are logged (comparing similarities and differences with respect to these same molecules in other living things) and molecules with a similar sequence
to theirs are observed in order to deduce their function and to classify them in the same order as the molecules already known.

The project also includes all genes and proteins ordered according to their behaviour in determined circumstances. To this end, it compares the same genes and proteins amongst healthy and unwell persons and amongst ill persons receiving different treatment. In this way, the behaviour of these molecules at different moments in the illness is registered.

Available on Internet

Once the function and behaviour of the genes and proteins are registered, this analysis tool detects anomalous behaviour of these molecules that could give rise to an illness and presents all this graphically as a map and thus, the doctor can anticipate the development of the illness. If the ailment has already initiated, this system enables a visual graphical representation of the overall cellular cycles involved in the illness and
provides information on the evolution of the sickness using the gathered data. Using the appropriate analyses, it enables the measurement of the efficiency of and patient response to the different treatments administered, thus enabling the identification of new, more effective therapeutic targets.

This new tool is available on Internet, thus enabling any biochemist working in genomics o proteonics to access the information generated in similar studies and research the similarities and comparisons which can throw light on some of the obscure aspects of many diseases.


'"/>

Source:Navarre University


Related biology news :

1. Ariadne Genomics Announces the Release of PathwayStudio?Central, Client-Server Software for Biological Pathway Analysis
2. Eliminate Data Analysis Bottlenecks in Drug Discovery
3. Analysis of flower genes reveals the fate of an ancient gene duplication
4. Genomatix Microarray Analysis Pipeline achieves Affymetrix GeneChip compatible?status
5. Analysis of breast-cancer gene role offers promising target
6. Analysis of rhesus monkey genome uncovers genetic differences with humans, chimps
7. FDA Approves Human Hookworm Vaccine for Phase I Safety Trials
8. New Clues Add 40,000 Years to Age of Human Species
9. Human Cells Filmed Instantly Messaging for First Time
10. Govt Creates Gene Database of Normal Human Tissues
11. Human Eggs Can Develop From Ovarian Surface Cells In Vitro
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/8/2017)... Feb. 7, 2017 Report Highlights ... The global synthetic-biology market ... billion by 2021, growing at a compound annual growth rate ... overview of the global markets for synthetic biology. - Analyses ... 2016, and projections of compound annual growth rates (CAGRs) through ...
(Date:2/7/2017)... BEACH, New York , February 7, 2017 /PRNewswire/ ... known as ID Global Solutions Corporation [OTC: IDGS], ("Ipsidy" ... identity management and electronic transaction processing services, is pleased ... reorganization of the Company. Effective January 31, ... of the Board of Directors, CEO and President.  An ...
(Date:2/2/2017)... , Feb. 2, 2017  EyeLock LLC, a ... a new white paper " What You Should Know ... problem of ensuring user authenticity is a growing concern. ... authentication of users. However, traditional authentication schemes such as ... Biometric authentication offers an elegant solution to ...
Breaking Biology News(10 mins):
(Date:2/24/2017)... Pa., Feb. 24, 2017  VWR Corporation (NASDAQ: VWR), the ... laboratory and production customers, today reported its financial results for ... Highlights: 4Q16 record quarterly ... 1.0% on an organic basis. ... an organic basis, while the Americas net sales increased 2.5%, ...
(Date:2/23/2017)... LONDON and NEW YORK ... at HIMSS, Lumeon , a leading digital ... (DN Telehealth), a provider of telemedicine and remote ... care pathways for telemedicine reimbursements.  ... and their patients, in real-time, extending consultations beyond ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... ... Drug Discovery Services portfolio to include an array of biochemical analyses critical ... reliable data to drive their hit-to-lead and SAR programs, including inhibitor potency and ...
(Date:2/23/2017)... 2017  MIODx announced today that it has ... technologies from the University of California, San Francisco ... monitor a patient for response to immune checkpoint ... second license extends the technology with a method ... have an immune-related adverse event (IRAE) from their ...
Breaking Biology Technology: